Abstract:Diabetes poses a serious threat to the health of people around the world. Therefore, in 2021, the World Health Organisation launched the Global Diabetes Compact, an initiative aimed at improving the management and prevention of diabetes. The rapid growth in the number of diabetic patients has increased the need for insulin. Rapid-acting human insulin analogues, including insulin aspart, improve the efficacy of insulin therapy. Methods for insulin aspart production include its biosynthesis in the proinsulin form in Escherichia coli . However, the yield of the recombinant protein largely depends on the optimisation of the production process. The aim of the study was to optimise the induction conditions for an E. coli strain expressing recombinant proinsulin aspart through applying the Design of Experiment (DoE) approach to enhance bacterial cell productivity. Materials and methods. The study focused on a strain of E. coli producing proinsulin aspart. The authors planned the experiment using MODDE software and the reduced face-centred central composite design (CCF) enabling the assessment of factor interactions and the creation of design spaces. The authors carried out fermentations of the producing strain in a 5 L Biostat® B bioreactor and measured proinsulin aspart concentrations by capillary gel electrophoresis. The results were analysed using GraphPad Prism 6. Results. Using the DoE approach, the authors optimised the conditions for the growth of the producer strain and the biosynthesis of proinsulin aspart. Based on data from response surface plots for wet biomass concentration, specific productivity, and volumetric productivity, as well as plotted models, the authors established design spaces for the induction of proinsulin aspart expression in E. coli . The plotted models demonstrated high predictive power and high reproducibility of the results. The authors successfully validated the induction process for the synthesis of proinsulin aspart in a bioreactor under optimised conditions. The volumetric productivity of the strain producing proinsulin aspart increased from 3.06±0.16 g/L (conventional conditions) to 4.93±0.80 g/L (optimised conditions). Conclusions. The authors achieved a 60% increase in the volumetric yield of proinsulin aspart. The study results may be used to intensify the industrial production of insulin aspart.

Production of Human Proinsulin Ine. Coli in a Non-Fusion Form

Production of Human Insulin in an E. Coli System with Met-Lys-human Proinsulin As the Expressed Precursor.

Secretive expression of human proinsulin gene at high level in E. coli

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein

High Level Expression and Purification of Recombinant Human Serum Albumin in Pichia Pastoris.

Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin

Cloning of CTB-PROIN fusion gene and its expression in Escherichia coli]

Production of recombinant human insulin from a promising Pseudomonas fluorescens cell factory and its kinetic modeling

High Efficient Expression and Purification of the Escherichia Coli T-protein

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Formation of inclusion bodies may be the key factor for the stability of expressed products in E. coli.

Construction,expression and purification of recombinant human insulin-like growth factor-1 precursor

Construction of Prokaryotic Expression Vector for Human Insulin-like Growth Factor-1 Gene and Biological Activity of Expressed Protein

Systematic High-Yield Production of Human Secreted Proteins in Escherichia Coli

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Auto-inducting Expression and Purification of Recombinant Human Anticoagulant Protein in Escherichia coli

Separation and Purification of Recombinant Human Insulin and C Peptide Expressed in the Yeast Pichia Pastoris

Optimisation of induction conditions for a bacterial strain producing proinsulin aspart

Expression and purification of recombinant human insulin from E. coli 20 strain